Quarterly report · Q1

Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥28.6bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥119.2bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥27.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥3.2bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥2.9bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥4.3bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥16.6bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.2bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥4.3bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥4.3bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥2.7bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥10.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.5bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥3.2bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥3.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥239.3bnat 2023-06-30Cons.Assets
Total assets¥236.5bnat 2023-03-31Cons.Assets
Total assets¥226.5bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥39.1bnat 2023-06-30Cons.Liabilities
Total liabilities¥40.1bnat 2023-03-31Cons.Liabilities
Net assets / equity¥200.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥196.4bnat 2023-03-31Cons.Net assets
Net assets / equity¥189.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥75.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥76.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥23.412023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥86.12022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio70.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥592m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥589m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30−¥20m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥447m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥447m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥314m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue2023-04-01 → 2023-06-30¥3.3bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue external2023-04-01 → 2023-06-30¥3.2bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥79m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentsegment profit2023-04-01 → 2023-06-30−¥126m
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue2023-04-01 → 2023-06-30¥13.8bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue external2023-04-01 → 2023-06-30¥13.4bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥349m
jpcrp040300-q1r_E00898-000Medicinereportable segmentsegment profit2023-04-01 → 2023-06-30¥2.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue2023-04-01 → 2023-06-30¥11.4bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue external2023-04-01 → 2023-06-30¥11.4bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥16m
jpcrp040300-q1r_E00898-000Processingreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-06-30¥28.5bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥28.0bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥444m
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥29.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥28.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥447m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥3.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥796m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥790m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥17m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥425m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥425m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥369m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue2022-04-01 → 2022-06-30¥3.1bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.0bn
jpcrp040300-q1r_E00898-000Equipmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥56m
jpcrp040300-q1r_E00898-000Equipmentreportable segmentsegment profit2022-04-01 → 2022-06-30−¥194m
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥12.7bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00898-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥354m
jpcrp040300-q1r_E00898-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥1.8bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue2022-04-01 → 2022-06-30¥11.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue external2022-04-01 → 2022-06-30¥11.1bn
jpcrp040300-q1r_E00898-000Processingreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥7m
jpcrp040300-q1r_E00898-000Processingreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.6bn
—segment totalrevenue2022-04-01 → 2022-06-30¥26.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥26.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥419m
—segment totalsegment profit2022-04-01 → 2022-06-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥27.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥27.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥425m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥3.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 407
ItemContextValueUnit
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass